|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
EBOOKCENTRAL_ocn797918439 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
120702s1979 ne ob 101 0 eng d |
040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d IDEBK
|d N$T
|d OCLCQ
|d OCLCF
|d OCLCO
|d OCLCQ
|d DEBSZ
|d OCLCO
|d OCLCQ
|d OCLCO
|d COO
|d OCL
|d OCLCO
|d OCL
|d OCLCO
|d OCLCQ
|d OCLCO
|d ZCU
|d OCLCQ
|d MERUC
|d OCLCQ
|d ICG
|d OCLCQ
|d WYU
|d DKC
|d AU@
|d OCLCQ
|d OCL
|d OCLCQ
|d OCL
|d OCLCQ
|d INARC
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1066493750
|
020 |
|
|
|a 9780470718193
|q (electronic bk.)
|
020 |
|
|
|a 0470718196
|q (electronic bk.)
|
020 |
|
|
|z 0444900888
|q (Elsevier/North-Holland)
|
020 |
|
|
|z 9021940744
|
020 |
|
|
|z 9780470663790
|
029 |
1 |
|
|a DEBBG
|b BV044154925
|
029 |
1 |
|
|a DEBSZ
|b 430999682
|
029 |
1 |
|
|a DEBSZ
|b 449245330
|
035 |
|
|
|a (OCoLC)797918439
|z (OCoLC)1066493750
|
050 |
|
4 |
|a QR188.35
|
072 |
|
7 |
|a MED
|x 027000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 060000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.3/99
|a 616.399
|
049 |
|
|
|a UAMI
|
111 |
2 |
|
|a Symposium on Enzyme Defects and Immune Dysfunction
|d (1978 :
|c London, England)
|
245 |
1 |
0 |
|a Enzyme Defects and Immune Dysfunction.
|
260 |
|
|
|a Amsterdam ;
|a New York :
|b Excerpta Medica,
|c 1979.
|
300 |
|
|
|a 1 online resource (301 pages)
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Ciba Foundation symposium ;
|v 68 (new ser.)
|
490 |
1 |
|
|a Novartis Foundation Symposia ;
|v v. 909
|
588 |
0 |
|
|a Print version record.
|
504 |
|
|
|a Includes bibliographical references and indexes.
|
505 |
0 |
|
|a Enzyme Defects and Immune Dysfunction; Contents; Chairman's introduction; Adenosine deaminase and purine nucleoside phosphorylase deficiency: how they were discovered and what they may mean; Discussion; Buridan's ass: one man's view of the immune system; Discussion; Clinical delineation of adenosine deaminase deficiency; Discussion; Immunological aberrations in purine nucleoside phosphorylase deficiencies; Discussion; Immunodeficiency due to transcobalamin II deficiency; Discussion; General Discussion I Model systems for study of enzyme deficiencies.
|
505 |
8 |
|
|a Nucleotide metabolism in cultured T cells and in cells of patients deficient in adenosine deaminase and purine nucleoside phosphorylaseDiscussion; Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents; Discussion; Ecto 5'-nucleotidase deficiency in primary hypogammaglobulinaemia; Discussion; General Discussion II The methylation hypothesis of adenosine toxicity; Enzymology of immunodeficiency states; Allosteric regulation of calf thymus ribonucleotide reductase; Discussion.
|
505 |
8 |
|
|a Adenosine deaminase: characteristics of the normal and mutant forms of the human enzymeDiscussion; Purine nucleoside phosphorylase: the normal enzyme and structural alterations in immunodeficiency disease; Discussion; Purine nucleoside phosphorylase : immunodetection and characterization of the human enzyme; Enzyme replacement and other biochemical approaches to the therapy of adenosine deaminase deficiency; Discussion; An approach to the restoration of T cell function in a purine nucleoside phosphorylase deficient patient; Discussion; Purine metabolism in adenosine deaminase deficiency.
|
505 |
8 |
|
|a Final General Discussion Selective treatment of lymphoid malignancy with adenosine deaminase inhibitorsDefects in differentiation underlying ADA and PNP deficiency; Search for new enzyme deficiencies; Index of contributors; Subject index.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Immunological deficiency syndromes
|v Congresses.
|
650 |
|
0 |
|a Adenosine deaminase
|v Congresses.
|
650 |
|
0 |
|a Purines
|x Metabolism
|v Congresses.
|
650 |
|
0 |
|a Enzymes
|v Congresses.
|
650 |
|
6 |
|a Syndromes de déficit immunitaire
|v Congrès.
|
650 |
|
6 |
|a Adénosine-désaminase
|v Congrès.
|
650 |
|
6 |
|a Purines
|x Métabolisme
|v Congrès.
|
650 |
|
6 |
|a Enzymes
|v Congrès.
|
650 |
|
7 |
|a MEDICAL
|x Endocrinology & Metabolism.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Nutrition.
|2 bisacsh
|
650 |
|
7 |
|a Adenosine deaminase
|2 fast
|
650 |
|
7 |
|a Enzymes
|2 fast
|
650 |
|
7 |
|a Immunological deficiency syndromes
|2 fast
|
650 |
|
7 |
|a Purines
|x Metabolism
|2 fast
|
655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|
776 |
0 |
8 |
|i Print version:
|a Symposium, CIBA Foundation.
|t Enzyme Defects and Immune Dysfunction.
|d Hoboken : John Wiley & amp; Sons, ©2009
|z 9780470663790
|
830 |
|
0 |
|a Ciba Foundation symposium ;
|v new ser. 68.
|
830 |
|
0 |
|a Novartis Foundation Symposia.
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=703890
|z Texto completo
|
938 |
|
|
|a Internet Archive
|b INAR
|n enzymedefectsimm0000symp
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL703890
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 465327
|
938 |
|
|
|a ProQuest MyiLibrary Digital eBook Collection
|b IDEB
|n 369418
|
994 |
|
|
|a 92
|b IZTAP
|